Lung CT Scans of COVID-19 Patients Can Predict Neurological Problems Revealed Later by Brain MRIs
By HospiMedica International staff writers Posted on 15 Mar 2021 |
Image: Achala Vagal, MD, author on the study, reviews an MRI scan (Photo courtesy of Colleen Kelley)
For the first time, a multicenter study has found a visual correlation between the severity of the disease in the lungs using CT scans and the severity of effects on patient’s brains, using MRI scans.
The results of the study led by University of Cincinnati (Cincinnati, OH, USA) show that by looking at lung CT scans of patients diagnosed with COVID-19, physicians may be able to predict just how badly they can experience other neurological problems that could show up on brain MRIs, helping improve patient outcomes and identify symptoms for earlier treatment. CT imaging can detect illness in the lungs better than an MRI, another medical imaging technique. However, MRI can detect many problems in the brain, particularly in COVID-19 patients, that cannot be detected on CT images.
In the study, researchers reviewed electronic medical records and images of hospitalized COVID-19 patients. Patients who were diagnosed with COVID-19, experienced neurological issues and who had both lung and brain images available were included. Out of 135 COVID-19 patients with abnormal CT lung scans and neurological symptoms, 49, or 36%, were also found to develop abnormal brain scans and were more likely to experience stroke symptoms.
The researchers believe that the study will help physicians classify patients, based on the severity of disease found on their CT scans, into groups more likely to develop brain imaging abnormalities. Additionally, the correlation could be important for implementing therapies, particularly in stroke prevention, to improve outcomes in patients with COVID-19.
“These results are important because they further show that severe lung disease from COVID-19 could mean serious brain complications, and we have the imaging to help prove it,” said Abdelkader Mahammedi, MD, assistant professor of radiology, UC Health radiologist and member of the UC Gardner Neuroscience Institute. “Future larger studies are needed to help us understand the tie better, but for now, we hope these results can be used to help predict care and ensure that patients have the best outcomes.”
Related Links:
University of Cincinnati
The results of the study led by University of Cincinnati (Cincinnati, OH, USA) show that by looking at lung CT scans of patients diagnosed with COVID-19, physicians may be able to predict just how badly they can experience other neurological problems that could show up on brain MRIs, helping improve patient outcomes and identify symptoms for earlier treatment. CT imaging can detect illness in the lungs better than an MRI, another medical imaging technique. However, MRI can detect many problems in the brain, particularly in COVID-19 patients, that cannot be detected on CT images.
In the study, researchers reviewed electronic medical records and images of hospitalized COVID-19 patients. Patients who were diagnosed with COVID-19, experienced neurological issues and who had both lung and brain images available were included. Out of 135 COVID-19 patients with abnormal CT lung scans and neurological symptoms, 49, or 36%, were also found to develop abnormal brain scans and were more likely to experience stroke symptoms.
The researchers believe that the study will help physicians classify patients, based on the severity of disease found on their CT scans, into groups more likely to develop brain imaging abnormalities. Additionally, the correlation could be important for implementing therapies, particularly in stroke prevention, to improve outcomes in patients with COVID-19.
“These results are important because they further show that severe lung disease from COVID-19 could mean serious brain complications, and we have the imaging to help prove it,” said Abdelkader Mahammedi, MD, assistant professor of radiology, UC Health radiologist and member of the UC Gardner Neuroscience Institute. “Future larger studies are needed to help us understand the tie better, but for now, we hope these results can be used to help predict care and ensure that patients have the best outcomes.”
Related Links:
University of Cincinnati
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Latest COVID-19 News
- Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles
- World's First Inhalable COVID-19 Vaccine Approved in China
- COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles
- Blood Viscosity Testing Can Predict Risk of Death in Hospitalized COVID-19 Patients
- ‘Covid Computer’ Uses AI to Detect COVID-19 from Chest CT Scans
- MRI Lung-Imaging Technique Shows Cause of Long-COVID Symptoms
- Chest CT Scans of COVID-19 Patients Could Help Distinguish Between SARS-CoV-2 Variants
- Specialized MRI Detects Lung Abnormalities in Non-Hospitalized Long COVID Patients
- AI Algorithm Identifies Hospitalized Patients at Highest Risk of Dying From COVID-19
- Sweat Sensor Detects Key Biomarkers That Provide Early Warning of COVID-19 and Flu
- Study Assesses Impact of COVID-19 on Ventilation/Perfusion Scintigraphy
- CT Imaging Study Finds Vaccination Reduces Risk of COVID-19 Associated Pulmonary Embolism
- Third Day in Hospital a ‘Tipping Point’ in Severity of COVID-19 Pneumonia
- Longer Interval Between COVID-19 Vaccines Generates Up to Nine Times as Many Antibodies
- AI Model for Monitoring COVID-19 Predicts Mortality Within First 30 Days of Admission
- AI Predicts COVID Prognosis at Near-Expert Level Based Off CT Scans